Keyphrases
Clostridium Difficile Infection
100%
Retrospective Case-Control Design
100%
C.difficile Infection
100%
Gaba
100%
Zolpidem
36%
Frequent Use
27%
GABA Modulators
27%
Multivariate Regression Model
18%
Propensity Score Analysis
18%
Risk Factors
9%
Antibiotics
9%
Neurotransmitters
9%
Nursing Homes
9%
Residency
9%
Aminobutyric Acid
9%
Non-associated
9%
Antibiotic Use
9%
Fluoroquinolones
9%
Gabapentin
9%
Benzodiazepines
9%
Sweden
9%
Infection Progression
9%
Cephalosporins
9%
Baclofen
9%
Clindamycin
9%
GABA Agonist
9%
Infection Recurrence
9%
Zopiclone
9%
Metabolomics Study
9%
Pregabalin
9%
General Association
9%
Pharmacology, Toxicology and Pharmaceutical Science
Case-Control Study
100%
Clostridium Difficile Infection
100%
Benzodiazepine Receptor Affecting Agent
100%
4 Aminobutyric Acid
50%
Zolpidem
33%
Antibiotics
8%
Recurrent Disease
8%
Neurotransmitter
8%
Aminobutyric Acid Derivative
8%
Gabapentin
8%
Cephalosporin Derivative
8%
Quinolone Derivative
8%
Baclofen
8%
Clindamycin
8%
4 Aminobutyric Acid Receptor Stimulating Agent
8%
Zopiclone
8%
Pregabalin
8%
Agricultural and Biological Sciences
Case-Control Study
100%
Clostridium difficile
100%
Gamma-Aminobutyric Acid
100%
Risk Factor
14%
Agonist
14%
Metabolomics
14%
Neurotransmitter
14%
Clindamycin
14%
Cephalosporin
14%